Vaccinia Virus News and Research

RSS
The vaccinia virus is the "live virus" used in the smallpox vaccine. It is a "pox"-type virus related to smallpox. When given to humans as a vaccine, it helps the body to develop immunity to smallpox. The smallpox vaccine does not contain the smallpox virus and it cannot cause smallpox.
How may the genetic differences observed in the current monkeypox virus outbreak impact immune responses induced by VACV vaccines?

How may the genetic differences observed in the current monkeypox virus outbreak impact immune responses induced by VACV vaccines?

The impact of gene amplification in virus adaptation through intermediate hosts

The impact of gene amplification in virus adaptation through intermediate hosts

Vaccination against smallpox efficiently protects against monkeypox infection

Vaccination against smallpox efficiently protects against monkeypox infection

Researchers investigate prevention and therapy against monkeypox infection

Researchers investigate prevention and therapy against monkeypox infection

Animal study suggests intranasal COVID vaccine delivery more efficient than intramuscular

Animal study suggests intranasal COVID vaccine delivery more efficient than intramuscular

Efficacy of MVA-CoV2-S vaccination to prevent SARS-CoV-2 cerebral infection and associated damage

Efficacy of MVA-CoV2-S vaccination to prevent SARS-CoV-2 cerebral infection and associated damage

Oral bacteria-based SARS-CoV-2 vaccine platform

Oral bacteria-based SARS-CoV-2 vaccine platform

New vaccinia-based COVID-19 vaccine candidate induces robust, durable immune responses

New vaccinia-based COVID-19 vaccine candidate induces robust, durable immune responses

Vaccinia-based COVID-19 vaccines confer immunity in hamster model

Vaccinia-based COVID-19 vaccines confer immunity in hamster model

CDC monitoring over 200 individuals possibly exposed to monkeypox

CDC monitoring over 200 individuals possibly exposed to monkeypox

Researchers review environmental risk assessments for recombinant COVID-19 viral vector vaccines

Researchers review environmental risk assessments for recombinant COVID-19 viral vector vaccines

Vaccines delivered via skin may offer better protection against respiratory diseases

Vaccines delivered via skin may offer better protection against respiratory diseases

MVA SARS-CoV-2 vaccine candidate shows strong immunogenicity in preclinical trials

MVA SARS-CoV-2 vaccine candidate shows strong immunogenicity in preclinical trials

Modified Vaccinia Ankara model vaccine prevents COVID-19 in transgenic mice study

Modified Vaccinia Ankara model vaccine prevents COVID-19 in transgenic mice study

Disinfectants with "virucidal activity against enveloped viruses" effective against SARS-CoV-2

Disinfectants with "virucidal activity against enveloped viruses" effective against SARS-CoV-2

Green tea and some fruit juices inhibit SARS-CoV-2 in vitro

Green tea and some fruit juices inhibit SARS-CoV-2 in vitro

Modified Vaccinia Ankara-based vaccine candidate for SARS-CoV-2

Modified Vaccinia Ankara-based vaccine candidate for SARS-CoV-2

A first-in-human trial with promising MERS coronavirus vaccine

A first-in-human trial with promising MERS coronavirus vaccine

GlobalData: China can use the lessons learnt from SARS epidemic to control Wuhan coronavirus

GlobalData: China can use the lessons learnt from SARS epidemic to control Wuhan coronavirus

Scientists solve 3D structure of vaccinia virus RNA polymerase

Scientists solve 3D structure of vaccinia virus RNA polymerase

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.